Cargando…

Aberrant promoter methylation of cancer-related genes in human breast cancer

The clinical relevance of aberrant DNA methylation is being increasingly recognized in breast cancer. The present study aimed to evaluate the promoter methylation status of seven candidate genes and to explore their potential use as a biomarker for the diagnosis of breast cancer. A total of 70 Chine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Liang, Shen, Ye, Peng, Xianzhen, Zhang, Simin, Wang, Ming, Xu, Guisheng, Zheng, Xianzhi, Wang, Jianming, Lu, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5228392/ https://www.ncbi.nlm.nih.gov/pubmed/28105221 http://dx.doi.org/10.3892/ol.2016.5351

Ejemplares similares

Is Tuberculosis Treatment Really Free in China? A Study Comparing Two Areas with Different Management Models
por: Qiu, Sangsang, et al.
Publicado: (2015)

Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China
por: Zheng, Xianzhi, et al.
Publicado: (2015)

Accumulated promoter methylation as a potential biomarker for esophageal cancer
por: Peng, Xianzhen, et al.
Publicado: (2016)

Aberrant promoter CpG methylation and its translational applications in breast cancer
por: Xiang, Ting-Xiu, et al.
Publicado: (2013)

Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic
por: Miao, Zhuang, et al.
Publicado: (2015)

Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer
por: Chen, Zi-Yi, et al.
Publicado: (2014)

Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer
por: Qi, Lina, et al.
Publicado: (2019)

miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer
por: Vrba, Lukas, et al.
Publicado: (2013)

Aberrant Promoter Methylation of YAP Gene and its Subsequent Downregulation in Indian Breast Cancer Patients
por: Real, Sumayya Abdul Sattar, et al.
Publicado: (2018)

Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer
por: Umeh-Garcia, Maxine, et al.
Publicado: (2022)

Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer
por: Han, Lin-Lin, et al.
Publicado: (2013)

Detection of aberrant methylation of a six-gene panel in serum DNA for diagnosis of breast cancer
por: Shan, Ming, et al.
Publicado: (2016)

Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype
por: Van der Auwera, I, et al.
Publicado: (2008)

Aberrant Promoter Methylation of the Tumour Suppressor RASSF10 and Its Growth Inhibitory Function in Breast Cancer
por: Richter, Antje M., et al.
Publicado: (2016)

Aberrant promoter methylation status is associated with upregulation of the E2F4 gene in breast cancer
por: Farman, Farman Ullah, et al.
Publicado: (2018)

Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer
por: Liu, Wentao, et al.
Publicado: (2018)

Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies
por: Zhou, Dan, et al.
Publicado: (2016)

Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer
por: Gonzalo, Victoria, et al.
Publicado: (2010)

Osteoponin Promoter Controlled by DNA Methylation: Aberrant Methylation in Cloned Porcine Genome
por: Shen, Chih-Jie, et al.
Publicado: (2014)

Chemoresistance of colorectal cancer to 5-fluorouracil is associated with silencing of the BNIP3 gene through aberrant methylation
por: He, Jianming, et al.
Publicado: (2017)

Aberrant DNA Methylation and Prostate Cancer
por: Majumdar, Sunipa, et al.
Publicado: (2011)

The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma
por: Lv, Zhenbing, et al.
Publicado: (2013)

APC gene promoter aberrant methylation in serum as a biomarker for breast cancer diagnosis: A meta‐analysis
por: Qian, Xiaojun, et al.
Publicado: (2018)

Idiopathic Male Infertility Is Strongly Associated with Aberrant Promoter Methylation of Methylenetetrahydrofolate Reductase (MTHFR)
por: Wu, Wei, et al.
Publicado: (2010)

Nidogen 1 and 2 gene promoters are aberrantly methylated in human gastrointestinal cancer
por: Ulazzi, Linda, et al.
Publicado: (2007)

Aberrant CBFA2T3B gene promoter methylation in breast tumors
por: Bais, Anthony J, et al.
Publicado: (2004)

Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report
por: Marzese, Diego M, et al.
Publicado: (2011)

Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies
por: Fang, Cheng, et al.
Publicado: (2015)

Aberrant alternative splicing in breast cancer
por: Yang, Quan, et al.
Publicado: (2019)

Field cancerization in the colon: a role for aberrant DNA methylation?
por: Luo, Yanxin, et al.
Publicado: (2014)

Aberrant Promoter Methylation at CpG Cytosines Induce the Upregulation of the E2F5 Gene in Breast Cancer
por: Ali, Arshad, et al.
Publicado: (2016)

Integrated analysis of promoter methylation and expression of telomere related genes in breast cancer
por: Heng, Jianfu, et al.
Publicado: (2017)

Aberrant PTPRO methylation in tumor tissues as a potential biomarker that predicts clinical outcomes in breast cancer patients
por: Li, Shao-ying, et al.
Publicado: (2014)

Aberrant methylation of SPARC in human lung cancers
por: Suzuki, M, et al.
Publicado: (2005)

Aberrant methylation of SPARC in human lung cancers
por: Suzuki, M, et al.
Publicado: (2013)

Aberrant DNA Methylation of ABC Transporters in Cancer
por: Zappe, Katja, et al.
Publicado: (2020)

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features
por: Wang, Lu, et al.
Publicado: (2016)

Detection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer
por: ZHANG, XIE, et al.
Publicado: (2014)

Aberrant Methylation of Aging-Related Genes in Asthma
por: Yang, Yu, et al.
Publicado: (2021)

Hyperinsulinemia promotes aberrant histone acetylation in triple-negative breast cancer
por: Senapati, Parijat, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ldgb6rakd2b1d7mufkdh19j18s